<DOC>
	<DOCNO>NCT02940756</DOCNO>
	<brief_summary>The Democratic Republic Congo ( DRC ) among country affect malaria Sub-Saharan Africa . Condidering size geographic position , DRC mean play major role malaria control region . The National Malaria Control program recommend artemisinin-based combination treatment ( ACTs ) , particular artesunate-amodiaquine artemether-lumefrantrine treatment uncomplicated malaria . Previous study indicate ACTs still effective , efficacy require threshold 90 % . It require assess regularly efficacy antimalarial drug , order ascertain relevance treatment guideline , case increase failure rate , alternative option decide ontime . The purpose trial ass efficacy safety artesunate-amodiaquine ( ASAQ Winthrop® ) , artemether-lumefantrine ( Coartem Dispersible® ) dihydro-artemisinin-piperaquine ( Eurartesim® ) day 42 treatment uncomplicated Plasmodium falciparum malaria six surveillance site around DRC .</brief_summary>
	<brief_title>Efficacy Safety Artemisinin-based Combination Treatments Democratic Republic Congo</brief_title>
	<detailed_description>This phase 4 , randomize , open label clinical trial , aim assess efficacy safety 3 ACTs treatment uncomplicated malaria Democratic Republic Congo . Children diagnose uncomplicated Plasmodium falciparum uncomplicated malaria randomize followed-up 42 day .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>child age 6 59 month axillary temperature ≥ 37.5 °C history fever 24 h recruitment monoinfection Plasmodium falciparum asexual parasite count 2,000 200,000/µL ability swallow oral medication ability willingness comply protocol duration study comply study visit schedule inform consent parent/guardian absence general danger sign sign severe falciparum malaria accord definition WHO ( 2000 ) absence severe malnutrition accord WHO child growth standard absence febrile condition due disease malaria ( e.g . measles , acute low respiratory tract infection , severe diarrhoea dehydration ) know underlie chronic severe disease ( e.g . cardiac , renal hepatic disease , HIV/AIDS ) absence regular medication , might interfere antimalarial pharmacokinetics absence history hypersensitivity reaction contraindication medicine test used alternative treatment presence general danger sign child age 5 year sign severe falciparum malaria accord definition WHO body weight &lt; 5kg hemoglobin level &lt; 5g/ dL mixed monoinfection another Plasmodium specie detect microscopy presence severe malnutrition presence febrile condition due disease malaria ( e.g . measles , acute low respiratory tract infection , severe diarrhoea dehydration ) know underlie chronic severe disease ( e.g . cardiac , renal hepatic disease , HIV/AIDS ) regular medication , may interfere antimalarial pharmacokinetics ; history hypersensitivity reaction contraindication medicine ( ) test used alternative treatment ( )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Malaria , efficacy , safety , ACT , DR Congo</keyword>
</DOC>